Cédric Rentier Email & Phone Number

Tokyo, Jp

Tokyo, Japan

I lead a multicultural team of experts to facilitate continuous pre-sales and post-sales support of Biotage drug discovery workflow solutions for Japanese and Asia Pacific customers and collaborators.

Tokyo, Japan

I lead a multicultural team of experts to promote Biotage workflow solutions and facilitate continuous pre-sales and post-sales support of Biotage drug discovery portfolio for Japanese and Asia Pacific customers and collaborators.

Tokyo, Japon

As a part of my growing responsibilities for the Japanese office of Biotage, I facilitate continuous pre-sales and post-sales Applications support of Biotage drug discovery portfolio across Asia Pacific distributors and customers as well as Biotage Asia regional offices (Japan, China, Korea, India), and corporate HQ (Sweden).

Tokyo, Japon

In addition to the previous technical specialist responsibilities, now coordinating and assisting the peptides & biomolecules marketing effort for Japan and Asia Pacific

Dans Les 23 Arrondissements De Tokyo, Japon

In addition to the previous responsibilities, dealing with pre-sales and post-sales technical and application support for the biomolecules product line (PhyNexus, PhyTip).

Dans Les 23 Arrondissements De Tokyo, Japon

Pre-sales and post-sales technical and application support for the peptide synthesis product line (Syro & Alstra).Liaison with management at Biotage HQ (Sweden) and Biotage Japan for reporting customer requests, providing scientific advising, updates on technological and research trends in Asia Pacific.

Tsukuba, Japan

Visiting Research Scientist at the KEK (High Energy Accelerator Research Organization), Structural Biology Research Center, Institute of Materials Structure Science. Directed by Prof. Toshiya Senda and Dr. Fumiaki Yumoto.Synthesis and isolation of myostatin protein, conformational studies and X-ray crystallography to evaluate interactions between myostatin protein and myostatin inhibitory peptides. Inhibition of myostatin, which negatively regulates skeletal muscle growth, is a promising strategy for the treatment of muscle atrophic disorders, such as muscular dystrophy, cachexia or sarcopenia.

Hachioji, Japan

JSPS Overseas Post doctoral fellow at Tokyo University of Pharmacy and Life Sciences in the laboratory of Prof. Yoshio Hayashi. Synthesis of peptides, conformational studies and in vitro cell-based assays to obtain potent myostatin inhibitors. Inhibition of myostatin, which negatively regulates skeletal muscle growth, is a promising strategy for the treatment of muscle atrophic disorders, such as muscular dystrophy, cachexia or sarcopenia.

Hachioji, Japan

MEXT Post doctoral fellow at Tokyo University of Pharmacy and Life Sciences in the laboratory of Prof. Yoshio Hayashi. Synthesis of peptides, conformational studies and in vitro cell-based assays to obtain potent myostatin inhibitors. Inhibition of myostatin, which negatively regulates skeletal muscle growth, is a promising strategy for the treatment of muscle atrophic disorders, such as muscular dystrophy, cachexia or sarcopenia.

Cergy-Pontoise, France

Teaching Assistant in theoretical and practical organic chemistry for students in Chemistry and Biology courses (1st year to 4th year).- Tutorials in Introduction to organic chemistry (1st year Bachelor students)- Basic practical laboratory work for students in organic chemistry (2nd & 3rd year Bachelor students)- Advanced practical laboratory work for students in organic chemistry (1st year Master students)

Cergy-Pontoise, France & Florence, Italy

PhD title: "Autoimmune diseases: design, synthesis and immunological screening of post-translationally modified peptides to characterize autoantibodies in patients'​ sera." Directed by Prof. Anna Maria Papini, Prof. Paolo Rovero, and Prof. Nadège Lubin-Germain.Cotutored project between Laboratoire de Chimie Biologique – EA 4505, University of Cergy-Pontoise (France), and Laboratory of Peptides, Proteins and Biology PeptLab, University of Florence (Italy).Defended on July, 17th 2015. Graduated summa cum laude with the congratulation of the jury. This research work aims to apply the novel concept of “Chemical Reverse Approach” to the design, the production, and the immunological screening of synthetic antigens able to specifically detect autoantibodies in sera of patients affected by immune-mediated diseases. Such specific autoantibodies are considered disease biomarkers and can be used to develop novel diagnostic/prognostic tools for the aforementioned pathologies.In particular, three diseases have been investigated: primary biliary cirrhosis, diabetes and multiple sclerosis.

Doctor Of Philosophy - Phd, Chemical Sciences And Chemical Biology, Summa Cum Laude With Congratulations Of The Jury

Doctor Of Philosophy - Phd, Chemical Sciences And Chemical Biology, Summa Cum Laude With Congratulations Of The Jury

Master'S Degree, Organic Chemistry, Polymers And Analysis, Summa Cum Laude (17.5/20)

Bachelor'S Degree, Chemistry & Physics, Cum Laude